TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astrazeneca A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
589,926
|
1,119,609
|
348,224 |
| Earnings before taxes |
34,624
|
47,775
|
12,732 |
| Total assets |
405,154
|
721,981
|
311,869 |
| Current assets |
398,055
|
359,140
|
309,407 |
| Current liabilities |
106,154
|
105,356
|
83,434 |
| Equity capital |
296,194
|
765,128
|
225,804 |
| - share capital |
85,968
|
80,686
|
76,448 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
73.1%
|
106.0%
|
72.4% |
| Turnover per employee |
7,866
|
14,928
|
4,643 |
| Profit as a percentage of turnover |
5.9%
|
4.3%
|
3.7% |
| Return on assets (ROA) | |||
| Current ratio |
375.0%
|
340.9%
|
370.8% |
| Return on equity (ROE) |
11.7%
|
6.2%
|
5.6% |
| Change turnover |
-602,984
|
752,081
|
4,568 |
| Change turnover % |
-51%
|
205%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.